首页 > 最新文献

Frontiers in radiology最新文献

英文 中文
RoMIA: a framework for creating Robust Medical Imaging AI models for chest radiographs. RoMIA:为胸片创建鲁棒医学成像人工智能模型的框架。
Pub Date : 2024-01-08 eCollection Date: 2023-01-01 DOI: 10.3389/fradi.2023.1274273
Aditi Anand, Sarada Krithivasan, Kaushik Roy

Artificial Intelligence (AI) methods, particularly Deep Neural Networks (DNNs), have shown great promise in a range of medical imaging tasks. However, the susceptibility of DNNs to producing erroneous outputs under the presence of input noise and variations is of great concern and one of the largest challenges to their adoption in medical settings. Towards addressing this challenge, we explore the robustness of DNNs trained for chest radiograph classification under a range of perturbations reflective of clinical settings. We propose RoMIA, a framework for the creation of Robust Medical Imaging AI models. RoMIA adds three key steps to the model training and deployment flow: (i) Noise-added training, wherein a part of the training data is synthetically transformed to represent common noise sources, (ii) Fine-tuning with input mixing, in which the model is refined with inputs formed by mixing data from the original training set with a small number of images from a different source, and (iii) DCT-based denoising, which removes a fraction of high-frequency components of each image before applying the model to classify it. We applied RoMIA to create six different robust models for classifying chest radiographs using the CheXpert dataset. We evaluated the models on the CheXphoto dataset, which consists of naturally and synthetically perturbed images intended to evaluate robustness. Models produced by RoMIA show 3%-5% improvement in robust accuracy, which corresponds to an average reduction of 22.6% in misclassifications. These results suggest that RoMIA can be a useful step towards enabling the adoption of AI models in medical imaging applications.

人工智能(AI)方法,尤其是深度神经网络(DNN),在一系列医学成像任务中显示出巨大的前景。然而,DNNs 在输入噪声和变化的情况下容易产生错误输出,这一点非常令人担忧,也是其在医疗环境中应用所面临的最大挑战之一。为了应对这一挑战,我们探索了在一系列反映临床环境的扰动下为胸片分类而训练的 DNN 的鲁棒性。我们提出了用于创建鲁棒医学影像人工智能模型的框架 RoMIA。RoMIA 在模型训练和部署流程中增加了三个关键步骤:(i) 添加噪声训练,即对部分训练数据进行合成转换,以代表常见的噪声源;(ii) 输入混合微调,即通过将原始训练集的数据与来自不同来源的少量图像混合形成的输入来完善模型;(iii) 基于 DCT 的去噪,即在应用模型进行分类之前去除每张图像的部分高频成分。我们应用 RoMIA 创建了六种不同的稳健模型,用于使用 CheXpert 数据集对胸部 X 光片进行分类。我们在 CheXphoto 数据集上对模型进行了评估,该数据集由自然和合成扰动图像组成,旨在评估鲁棒性。由 RoMIA 生成的模型在鲁棒性准确性方面提高了 3%-5%,相当于平均减少了 22.6% 的错误分类。这些结果表明,RoMIA 可以成为医疗成像应用中采用人工智能模型的有用步骤。
{"title":"RoMIA: a framework for creating Robust Medical Imaging AI models for chest radiographs.","authors":"Aditi Anand, Sarada Krithivasan, Kaushik Roy","doi":"10.3389/fradi.2023.1274273","DOIUrl":"10.3389/fradi.2023.1274273","url":null,"abstract":"<p><p>Artificial Intelligence (AI) methods, particularly Deep Neural Networks (DNNs), have shown great promise in a range of medical imaging tasks. However, the susceptibility of DNNs to producing erroneous outputs under the presence of input noise and variations is of great concern and one of the largest challenges to their adoption in medical settings. Towards addressing this challenge, we explore the robustness of DNNs trained for chest radiograph classification under a range of perturbations reflective of clinical settings. We propose RoMIA, a framework for the creation of Robust Medical Imaging AI models. RoMIA adds three key steps to the model training and deployment flow: (i) Noise-added training, wherein a part of the training data is synthetically transformed to represent common noise sources, (ii) Fine-tuning with input mixing, in which the model is refined with inputs formed by mixing data from the original training set with a small number of images from a different source, and (iii) DCT-based denoising, which removes a fraction of high-frequency components of each image before applying the model to classify it. We applied RoMIA to create six different robust models for classifying chest radiographs using the CheXpert dataset. We evaluated the models on the CheXphoto dataset, which consists of naturally and synthetically perturbed images intended to evaluate robustness. Models produced by RoMIA show 3%-5% improvement in robust accuracy, which corresponds to an average reduction of 22.6% in misclassifications. These results suggest that RoMIA can be a useful step towards enabling the adoption of AI models in medical imaging applications.</p>","PeriodicalId":73101,"journal":{"name":"Frontiers in radiology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10800823/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139522371","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Imaging spectrum of amyloid-related imaging abnormalities associated with aducanumab immunotherapy 与阿杜单抗免疫疗法相关的淀粉样蛋白相关成像异常的成像谱
Pub Date : 2024-01-05 DOI: 10.3389/fradi.2023.1305390
H. Sotoudeh, Mohammadreza Alizadeh, Ramin Shahidi, Parnian Shobeiri, Z. Saadatpour, C. A. Wheeler, Marissa Natelson Love, Manoj Tanwar
Alzheimer's Disease (AD) is a leading cause of morbidity. Management of AD has traditionally been aimed at symptom relief rather than disease modification. Recently, AD research has begun to shift focus towards disease-modifying therapies that can alter the progression of AD. In this context, a class of immunotherapy agents known as monoclonal antibodies target diverse cerebral amyloid-beta (Aβ) epitopes to inhibit disease progression. Aducanumab was authorized by the US Food and Drug Administration (FDA) to treat AD on June 7, 2021. Aducanumab has shown promising clinical and biomarker efficacy but is associated with amyloid-related imaging abnormalities (ARIA). Neuroradiologists play a critical role in diagnosing ARIA, necessitating familiarity with this condition. This pictorial review will appraise the radiologic presentation of ARIA in patients on aducanumab.
阿尔茨海默病(AD)是发病率最高的疾病。对阿尔茨海默病的治疗历来以缓解症状而非改变病情为目标。最近,老年痴呆症研究的重点开始转向能够改变老年痴呆症病情发展的治疗方法。在这种情况下,一类被称为单克隆抗体的免疫疗法制剂以不同的脑淀粉样蛋白-β(Aβ)表位为靶点,抑制疾病的进展。阿杜单抗于2021年6月7日获得美国食品药品管理局(FDA)授权用于治疗AD。阿杜单抗已显示出良好的临床和生物标志物疗效,但与淀粉样蛋白相关的成像异常(ARIA)有关。神经放射科医生在诊断 ARIA 方面起着至关重要的作用,因此必须熟悉这种情况。本图解综述将评估阿杜单抗患者 ARIA 的放射学表现。
{"title":"Imaging spectrum of amyloid-related imaging abnormalities associated with aducanumab immunotherapy","authors":"H. Sotoudeh, Mohammadreza Alizadeh, Ramin Shahidi, Parnian Shobeiri, Z. Saadatpour, C. A. Wheeler, Marissa Natelson Love, Manoj Tanwar","doi":"10.3389/fradi.2023.1305390","DOIUrl":"https://doi.org/10.3389/fradi.2023.1305390","url":null,"abstract":"Alzheimer's Disease (AD) is a leading cause of morbidity. Management of AD has traditionally been aimed at symptom relief rather than disease modification. Recently, AD research has begun to shift focus towards disease-modifying therapies that can alter the progression of AD. In this context, a class of immunotherapy agents known as monoclonal antibodies target diverse cerebral amyloid-beta (Aβ) epitopes to inhibit disease progression. Aducanumab was authorized by the US Food and Drug Administration (FDA) to treat AD on June 7, 2021. Aducanumab has shown promising clinical and biomarker efficacy but is associated with amyloid-related imaging abnormalities (ARIA). Neuroradiologists play a critical role in diagnosing ARIA, necessitating familiarity with this condition. This pictorial review will appraise the radiologic presentation of ARIA in patients on aducanumab.","PeriodicalId":73101,"journal":{"name":"Frontiers in radiology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-01-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139383592","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Empowering breast cancer diagnosis and radiology practice: advances in artificial intelligence for contrast-enhanced mammography 增强乳腺癌诊断和放射学实践能力:造影剂增强乳腺 X 射线摄影的人工智能进展
Pub Date : 2024-01-05 DOI: 10.3389/fradi.2023.1326831
Ketki Kinkar, Brandon K. K. Fields, Mary W. Yamashita, Bino A. Varghese
Artificial intelligence (AI) applications in breast imaging span a wide range of tasks including decision support, risk assessment, patient management, quality assessment, treatment response assessment and image enhancement. However, their integration into the clinical workflow has been slow due to the lack of a consensus on data quality, benchmarked robust implementation, and consensus-based guidelines to ensure standardization and generalization. Contrast-enhanced mammography (CEM) has improved sensitivity and specificity compared to current standards of breast cancer diagnostic imaging i.e., mammography (MG) and/or conventional ultrasound (US), with comparable accuracy to MRI (current diagnostic imaging benchmark), but at a much lower cost and higher throughput. This makes CEM an excellent tool for widespread breast lesion characterization for all women, including underserved and minority women. Underlining the critical need for early detection and accurate diagnosis of breast cancer, this review examines the limitations of conventional approaches and reveals how AI can help overcome them. The Methodical approaches, such as image processing, feature extraction, quantitative analysis, lesion classification, lesion segmentation, integration with clinical data, early detection, and screening support have been carefully analysed in recent studies addressing breast cancer detection and diagnosis. Recent guidelines described by Checklist for Artificial Intelligence in Medical Imaging (CLAIM) to establish a robust framework for rigorous evaluation and surveying has inspired the current review criteria.
人工智能(AI)在乳腺成像中的应用范围广泛,包括决策支持、风险评估、患者管理、质量评估、治疗反应评估和图像增强。然而,由于缺乏对数据质量的共识、以基准为基础的稳健实施以及基于共识的指南来确保标准化和通用化,它们与临床工作流程的整合一直进展缓慢。与目前的乳腺癌诊断成像标准(即乳腺 X 线照相术(MG)和/或传统超声波(US))相比,对比增强乳腺 X 线照相术(CEM)具有更高的灵敏度和特异性,其准确性与核磁共振成像(目前的诊断成像基准)相当,但成本更低,吞吐量更大。这使得 CEM 成为一种优秀的工具,可广泛用于所有妇女(包括服务不足的妇女和少数民族妇女)的乳腺病变特征描述。本综述强调了早期检测和准确诊断乳腺癌的迫切需要,探讨了传统方法的局限性,并揭示了人工智能如何帮助克服这些局限性。在最近针对乳腺癌检测和诊断的研究中,对图像处理、特征提取、定量分析、病灶分类、病灶分割、与临床数据整合、早期检测和筛查支持等方法进行了仔细分析。医学影像人工智能核对表(CLAIM)所描述的最新指导方针为严格的评估和调查建立了一个稳健的框架,这也启发了当前的审查标准。
{"title":"Empowering breast cancer diagnosis and radiology practice: advances in artificial intelligence for contrast-enhanced mammography","authors":"Ketki Kinkar, Brandon K. K. Fields, Mary W. Yamashita, Bino A. Varghese","doi":"10.3389/fradi.2023.1326831","DOIUrl":"https://doi.org/10.3389/fradi.2023.1326831","url":null,"abstract":"Artificial intelligence (AI) applications in breast imaging span a wide range of tasks including decision support, risk assessment, patient management, quality assessment, treatment response assessment and image enhancement. However, their integration into the clinical workflow has been slow due to the lack of a consensus on data quality, benchmarked robust implementation, and consensus-based guidelines to ensure standardization and generalization. Contrast-enhanced mammography (CEM) has improved sensitivity and specificity compared to current standards of breast cancer diagnostic imaging i.e., mammography (MG) and/or conventional ultrasound (US), with comparable accuracy to MRI (current diagnostic imaging benchmark), but at a much lower cost and higher throughput. This makes CEM an excellent tool for widespread breast lesion characterization for all women, including underserved and minority women. Underlining the critical need for early detection and accurate diagnosis of breast cancer, this review examines the limitations of conventional approaches and reveals how AI can help overcome them. The Methodical approaches, such as image processing, feature extraction, quantitative analysis, lesion classification, lesion segmentation, integration with clinical data, early detection, and screening support have been carefully analysed in recent studies addressing breast cancer detection and diagnosis. Recent guidelines described by Checklist for Artificial Intelligence in Medical Imaging (CLAIM) to establish a robust framework for rigorous evaluation and surveying has inspired the current review criteria.","PeriodicalId":73101,"journal":{"name":"Frontiers in radiology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-01-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139382926","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial: Rising stars in neuroradiology: 2022 社论:神经放射学的新星:2022 年
Pub Date : 2024-01-05 DOI: 10.3389/fradi.2023.1349600
Thomas C. Booth
{"title":"Editorial: Rising stars in neuroradiology: 2022","authors":"Thomas C. Booth","doi":"10.3389/fradi.2023.1349600","DOIUrl":"https://doi.org/10.3389/fradi.2023.1349600","url":null,"abstract":"","PeriodicalId":73101,"journal":{"name":"Frontiers in radiology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-01-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139384013","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial: Radiomics and radiogenomics in genitourinary oncology: artificial intelligence and deep learning applications 社论:泌尿生殖系统肿瘤学中的放射组学和放射基因组学:人工智能和深度学习应用
Pub Date : 2023-12-18 DOI: 10.3389/fradi.2023.1325594
Alessandro Stefano, Elena Bertelli, A. Comelli, Marco Gatti, A. Stanzione
{"title":"Editorial: Radiomics and radiogenomics in genitourinary oncology: artificial intelligence and deep learning applications","authors":"Alessandro Stefano, Elena Bertelli, A. Comelli, Marco Gatti, A. Stanzione","doi":"10.3389/fradi.2023.1325594","DOIUrl":"https://doi.org/10.3389/fradi.2023.1325594","url":null,"abstract":"","PeriodicalId":73101,"journal":{"name":"Frontiers in radiology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139173884","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Standardized brain tumor imaging protocols for clinical trials: current recommendations and tips for integration 用于临床试验的标准化脑肿瘤成像协议:当前建议和整合提示
Pub Date : 2023-12-13 DOI: 10.3389/fradi.2023.1267615
F. Sanvito, Timothy J. Kaufmann, T. Cloughesy, Patrick Y. Wen, B. Ellingson
Standardized MRI acquisition protocols are crucial for reducing the measurement and interpretation variability associated with response assessment in brain tumor clinical trials. The main challenge is that standardized protocols should ensure high image quality while maximizing the number of institutions meeting the acquisition requirements. In recent years, extensive effort has been made by consensus groups to propose different “ideal” and “minimum requirements” brain tumor imaging protocols (BTIPs) for gliomas, brain metastases (BM), and primary central nervous system lymphomas (PCSNL). In clinical practice, BTIPs for clinical trials can be easily integrated with additional MRI sequences that may be desired for clinical patient management at individual sites. In this review, we summarize the general concepts behind the choice and timing of sequences included in the current recommended BTIPs, we provide a comparative overview, and discuss tips and caveats to integrate additional clinical or research sequences while preserving the recommended BTIPs. Finally, we also reflect on potential future directions for brain tumor imaging in clinical trials.
标准化的磁共振成像采集方案对于减少脑肿瘤临床试验中与反应评估相关的测量和解释变异性至关重要。主要的挑战在于,标准化方案既要确保高图像质量,又要最大限度地增加符合采集要求的机构数量。近年来,共识小组做出了大量努力,针对胶质瘤、脑转移瘤(BM)和原发性中枢神经系统淋巴瘤(PCSNL)提出了不同的 "理想 "和 "最低要求 "脑肿瘤成像方案(BTIPs)。在临床实践中,用于临床试验的 BTIPs 可以很容易地与个别部位临床患者管理所需的其他 MRI 序列相结合。在这篇综述中,我们总结了当前推荐的 BTIPs 所包含的序列选择和时间安排背后的一般概念,提供了比较概述,并讨论了在保留推荐的 BTIPs 的同时整合其他临床或研究序列的技巧和注意事项。最后,我们还对临床试验中脑肿瘤成像的未来潜在方向进行了思考。
{"title":"Standardized brain tumor imaging protocols for clinical trials: current recommendations and tips for integration","authors":"F. Sanvito, Timothy J. Kaufmann, T. Cloughesy, Patrick Y. Wen, B. Ellingson","doi":"10.3389/fradi.2023.1267615","DOIUrl":"https://doi.org/10.3389/fradi.2023.1267615","url":null,"abstract":"Standardized MRI acquisition protocols are crucial for reducing the measurement and interpretation variability associated with response assessment in brain tumor clinical trials. The main challenge is that standardized protocols should ensure high image quality while maximizing the number of institutions meeting the acquisition requirements. In recent years, extensive effort has been made by consensus groups to propose different “ideal” and “minimum requirements” brain tumor imaging protocols (BTIPs) for gliomas, brain metastases (BM), and primary central nervous system lymphomas (PCSNL). In clinical practice, BTIPs for clinical trials can be easily integrated with additional MRI sequences that may be desired for clinical patient management at individual sites. In this review, we summarize the general concepts behind the choice and timing of sequences included in the current recommended BTIPs, we provide a comparative overview, and discuss tips and caveats to integrate additional clinical or research sequences while preserving the recommended BTIPs. Finally, we also reflect on potential future directions for brain tumor imaging in clinical trials.","PeriodicalId":73101,"journal":{"name":"Frontiers in radiology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139004949","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Feasibility of four-dimensional similarity filter for radiation dose reduction in dynamic myocardial computed tomography perfusion imaging. 四维相似性滤波器在动态心肌计算机断层扫描灌注成像中减少辐射剂量的可行性。
Pub Date : 2023-12-01 eCollection Date: 2023-01-01 DOI: 10.3389/fradi.2023.1214521
Yuta Yamamoto, Yuki Tanabe, Akira Kurata, Shuhei Yamamoto, Tomoyuki Kido, Teruyoshi Uetani, Shuntaro Ikeda, Shota Nakano, Osamu Yamaguchi, Teruhito Kido

Rationale and objectives: We aimed to evaluate the impact of four-dimensional noise reduction filtering using a four-dimensional similarity filter (4D-SF) on radiation dose reduction in dynamic myocardial computed tomography perfusion (CTP).

Materials and methods: Forty-three patients who underwent dynamic myocardial CTP using 320-row computed tomography (CT) were included in the study. The original images were reconstructed using iterative reconstruction (IR). Three different CTP datasets with simulated noise, corresponding to 25%, 50%, and 75% reduction of the original dose (300 mA), were reconstructed using a combination of IR and 4D-SF. The signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR) were assessed, and CT-derived myocardial blood flow (CT-MBF) was quantified. The results were compared between the original and simulated images with radiation dose reduction.

Results: The median SNR (first quartile-third quartile) at the original, 25%-, 50%-, and 75%-dose reduced-simulated images with 4D-SF was 8.3 (6.5-10.2), 16.5 (11.9-21.7), 15.6 (11.0-20.1), and 12.8 (8.8-18.1) and that of CNR was 4.4 (3.2-5.8), 6.7 (4.6-10.3), 6.6 (4.3-10.1), and 5.5 (3.5-9.1), respectively. All the dose-reduced-simulated CTPs with 4D-SF had significantly higher image quality scores in SNR and CNR than the original ones (25%-, 50%-, and 75%-dose reduced vs. original images, p < 0.05, in each). The CT-MBF in 75%-dose reduced-simulated CTP was significantly lower than 25%-, 50%- dose-reduced-simulated, and original CTPs (vs. 75%-dose reduced-simulated images, p < 0.05, in each).

Conclusion: 4D-SF has the potential to reduce the radiation dose associated with dynamic myocardial CTP imaging by half, without impairing the robustness of MBF quantification.

原理和目的:我们旨在评估使用四维相似性过滤器(4D-SF)进行四维降噪过滤对减少动态心肌计算机断层扫描灌注(CTP)辐射剂量的影响:研究对象包括 43 名使用 320 排计算机断层扫描(CT)进行动态心肌 CTP 的患者。原始图像采用迭代重建(IR)技术进行重建。使用 IR 和 4D-SF 组合重建了三个不同的模拟噪声 CTP 数据集,分别相当于原始剂量(300 mA)的 25%、50% 和 75%。对信噪比(SNR)和对比度-噪声比(CNR)进行了评估,并对 CT 衍生的心肌血流(CT-MBF)进行了量化。结果比较了原始图像和减少辐射剂量后的模拟图像:结果:原始图像、25%、50% 和 75% 剂量减少后的 4D-SF 模拟图像的信噪比中位数(第一四分位数-第三四分位数)分别为 8.3(6.5-10.2)、16.5(11.9-21.7)、16.5(11.9-21.7)和 16.5(11.9-21.7)。5(11.9-21.7)、15.6(11.0-20.1)和 12.8(8.8-18.1),CNR 分别为 4.4(3.2-5.8)、6.7(4.6-10.3)、6.6(4.3-10.1)和 5.5(3.5-9.1)。所有使用 4D-SF 的剂量减低模拟 CTP 在 SNR 和 CNR 方面的图像质量评分都明显高于原始图像(25%、50% 和 75% 剂量减低与原始图像对比,P P 结论:4D-SF 有可能将动态心肌 CTP 成像的辐射剂量减少一半,而不影响 MBF 定量的稳健性。
{"title":"Feasibility of four-dimensional similarity filter for radiation dose reduction in dynamic myocardial computed tomography perfusion imaging.","authors":"Yuta Yamamoto, Yuki Tanabe, Akira Kurata, Shuhei Yamamoto, Tomoyuki Kido, Teruyoshi Uetani, Shuntaro Ikeda, Shota Nakano, Osamu Yamaguchi, Teruhito Kido","doi":"10.3389/fradi.2023.1214521","DOIUrl":"https://doi.org/10.3389/fradi.2023.1214521","url":null,"abstract":"<p><strong>Rationale and objectives: </strong>We aimed to evaluate the impact of four-dimensional noise reduction filtering using a four-dimensional similarity filter (4D-SF) on radiation dose reduction in dynamic myocardial computed tomography perfusion (CTP).</p><p><strong>Materials and methods: </strong>Forty-three patients who underwent dynamic myocardial CTP using 320-row computed tomography (CT) were included in the study. The original images were reconstructed using iterative reconstruction (IR). Three different CTP datasets with simulated noise, corresponding to 25%, 50%, and 75% reduction of the original dose (300 mA), were reconstructed using a combination of IR and 4D-SF. The signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR) were assessed, and CT-derived myocardial blood flow (CT-MBF) was quantified. The results were compared between the original and simulated images with radiation dose reduction.</p><p><strong>Results: </strong>The median SNR (first quartile-third quartile) at the original, 25%-, 50%-, and 75%-dose reduced-simulated images with 4D-SF was 8.3 (6.5-10.2), 16.5 (11.9-21.7), 15.6 (11.0-20.1), and 12.8 (8.8-18.1) and that of CNR was 4.4 (3.2-5.8), 6.7 (4.6-10.3), 6.6 (4.3-10.1), and 5.5 (3.5-9.1), respectively. All the dose-reduced-simulated CTPs with 4D-SF had significantly higher image quality scores in SNR and CNR than the original ones (25%-, 50%-, and 75%-dose reduced vs. original images, <i>p</i> < 0.05, in each). The CT-MBF in 75%-dose reduced-simulated CTP was significantly lower than 25%-, 50%- dose-reduced-simulated, and original CTPs (vs. 75%-dose reduced-simulated images, <i>p</i> < 0.05, in each).</p><p><strong>Conclusion: </strong>4D-SF has the potential to reduce the radiation dose associated with dynamic myocardial CTP imaging by half, without impairing the robustness of MBF quantification.</p>","PeriodicalId":73101,"journal":{"name":"Frontiers in radiology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10722229/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138814458","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Factors affecting the labelling accuracy of brain MRI studies relevant for deep learning abnormality detection. 影响深度学习异常检测相关脑磁共振成像研究标记准确性的因素。
Pub Date : 2023-11-27 eCollection Date: 2023-01-01 DOI: 10.3389/fradi.2023.1251825
Matthew Benger, David A Wood, Sina Kafiabadi, Aisha Al Busaidi, Emily Guilhem, Jeremy Lynch, Matthew Townend, Antanas Montvila, Juveria Siddiqui, Naveen Gadapa, Gareth Barker, Sebastian Ourselin, James H Cole, Thomas C Booth

Unlocking the vast potential of deep learning-based computer vision classification systems necessitates large data sets for model training. Natural Language Processing (NLP)-involving automation of dataset labelling-represents a potential avenue to achieve this. However, many aspects of NLP for dataset labelling remain unvalidated. Expert radiologists manually labelled over 5,000 MRI head reports in order to develop a deep learning-based neuroradiology NLP report classifier. Our results demonstrate that binary labels (normal vs. abnormal) showed high rates of accuracy, even when only two MRI sequences (T2-weighted and those based on diffusion weighted imaging) were employed as opposed to all sequences in an examination. Meanwhile, the accuracy of more specific labelling for multiple disease categories was variable and dependent on the category. Finally, resultant model performance was shown to be dependent on the expertise of the original labeller, with worse performance seen with non-expert vs. expert labellers.

要发掘基于深度学习的计算机视觉分类系统的巨大潜力,就必须使用大型数据集进行模型训练。自然语言处理(NLP)涉及数据集标签的自动化,是实现这一目标的潜在途径。然而,用于数据集标注的 NLP 的许多方面仍未得到验证。为了开发基于深度学习的神经放射学 NLP 报告分类器,放射学专家对 5000 多份磁共振成像头颅报告进行了人工标注。我们的研究结果表明,二元标签(正常与异常)显示出很高的准确率,即使只使用两种磁共振成像序列(T2 加权和基于弥散加权成像的序列),而不是检查中的所有序列。同时,对多种疾病类别进行更具体标记的准确率也不尽相同,而且取决于疾病类别。最后,结果模型的性能取决于原始标注者的专业知识,非专业标注者与专业标注者的性能相比更差。
{"title":"Factors affecting the labelling accuracy of brain MRI studies relevant for deep learning abnormality detection.","authors":"Matthew Benger, David A Wood, Sina Kafiabadi, Aisha Al Busaidi, Emily Guilhem, Jeremy Lynch, Matthew Townend, Antanas Montvila, Juveria Siddiqui, Naveen Gadapa, Gareth Barker, Sebastian Ourselin, James H Cole, Thomas C Booth","doi":"10.3389/fradi.2023.1251825","DOIUrl":"10.3389/fradi.2023.1251825","url":null,"abstract":"<p><p>Unlocking the vast potential of deep learning-based computer vision classification systems necessitates large data sets for model training. Natural Language Processing (NLP)-involving automation of dataset labelling-represents a potential avenue to achieve this. However, many aspects of NLP for dataset labelling remain unvalidated. Expert radiologists manually labelled over 5,000 MRI head reports in order to develop a deep learning-based neuroradiology NLP report classifier. Our results demonstrate that binary labels (normal vs. abnormal) showed high rates of accuracy, even when only two MRI sequences (T2-weighted and those based on diffusion weighted imaging) were employed as opposed to all sequences in an examination. Meanwhile, the accuracy of more specific labelling for multiple disease categories was variable and dependent on the category. Finally, resultant model performance was shown to be dependent on the expertise of the original labeller, with worse performance seen with non-expert vs. expert labellers.</p>","PeriodicalId":73101,"journal":{"name":"Frontiers in radiology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10711054/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138814423","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Radiomic analysis of the proximal femur in osteoporosis women using 3T MRI. 使用 3T 核磁共振成像对骨质疏松症女性股骨近端进行放射学分析。
Pub Date : 2023-11-21 eCollection Date: 2023-01-01 DOI: 10.3389/fradi.2023.1293865
Dimitri Martel, Anmol Monga, Gregory Chang

Introduction: Osteoporosis (OP) results in weak bone and can ultimately lead to fracture. MRI assessment of bone structure and microarchitecture has been proposed as method to assess bone quality and fracture risk in vivo. Radiomics provides a framework to analyze the textural information of MR images. The purpose of this study was to analyze the radiomic features and its abilityto differentiate between subjects with and without prior fragility fracture.

Methods: MRI acquisition was performed on n = 45 female OP subjects: 15 with fracture history (Fx) and 30 without fracture history (nFx) using a high-resolution 3D Fast Low Angle Shot (FLASH) sequence at 3T. Second and first order radiomic features were calculated in the trabecular region of the proximal femur on T1-weighted MRI signal of a matched dataset. Significance of the feature's predictive ability was measured using Wilcoxon test and Area Under the ROC (AUROC) curve analysis. The features were correlated DXA and FRAX score.

Result: A set of three independent radiomic features (Dependence Non-Uniformity (DNU), Low Gray Level Emphasis (LGLE) and Kurtosis) showed significant ability to predict fragility fracture (AUROC DNU = 0.751, p < 0.05; AUROC LGLE = 0.729, p < 0.05; AUROC Kurtosis = 0.718, p < 0.05) with low to moderate correlation with FRAX and DXA.

Conclusion: Radiomic features can measure bone health in MRI of proximal femur and has the potential to predict fracture.

导言骨质疏松症(OP)会导致骨质脆弱,最终导致骨折。磁共振成像评估骨结构和微结构已被提出作为评估体内骨质和骨折风险的方法。放射组学提供了一个分析核磁共振图像纹理信息的框架。本研究的目的是分析放射组学特征及其区分有无脆性骨折受试者的能力:对 n = 45 名女性 OP 受试者进行磁共振成像采集:方法:在 3T 下使用高分辨率三维快速低角度扫描 (FLASH) 序列对 n = 45 名女性 OP 受试者进行 MRI 采集:15 名有骨折史 (Fx),30 名无骨折史 (nFx)。根据匹配数据集的 T1 加权磁共振成像信号,计算股骨近端小梁区域的二阶和一阶放射学特征。采用 Wilcoxon 检验和 ROC 曲线下面积(AUROC)分析来衡量特征预测能力的显著性。这些特征与 DXA 和 FRAX 评分相关:结果:一组三个独立的放射学特征(依存性不均匀度(DNU)、低灰度级强调(LGLE)和峰度)显示出预测脆性骨折的显著能力(AUROC DNU = 0.751, p p p 结论:放射学特征可以测量骨健康状况:放射线组学特征可测量股骨近端核磁共振成像中的骨健康状况,并具有预测骨折的潜力。
{"title":"Radiomic analysis of the proximal femur in osteoporosis women using 3T MRI.","authors":"Dimitri Martel, Anmol Monga, Gregory Chang","doi":"10.3389/fradi.2023.1293865","DOIUrl":"10.3389/fradi.2023.1293865","url":null,"abstract":"<p><strong>Introduction: </strong>Osteoporosis (OP) results in weak bone and can ultimately lead to fracture. MRI assessment of bone structure and microarchitecture has been proposed as method to assess bone quality and fracture risk <i>in vivo</i>. Radiomics provides a framework to analyze the textural information of MR images. The purpose of this study was to analyze the radiomic features and its abilityto differentiate between subjects with and without prior fragility fracture.</p><p><strong>Methods: </strong>MRI acquisition was performed on <i>n </i>= 45 female OP subjects: 15 with fracture history (Fx) and 30 without fracture history (nFx) using a high-resolution 3D Fast Low Angle Shot (FLASH) sequence at 3T. Second and first order radiomic features were calculated in the trabecular region of the proximal femur on T1-weighted MRI signal of a matched dataset. Significance of the feature's predictive ability was measured using Wilcoxon test and Area Under the ROC (AUROC) curve analysis. The features were correlated DXA and FRAX score.</p><p><strong>Result: </strong>A set of three independent radiomic features (Dependence Non-Uniformity (DNU), Low Gray Level Emphasis (LGLE) and Kurtosis) showed significant ability to predict fragility fracture (AUROC DNU = 0.751, <i>p</i> < 0.05; AUROC LGLE = 0.729, <i>p</i> < 0.05; AUROC Kurtosis = 0.718, <i>p</i> < 0.05) with low to moderate correlation with FRAX and DXA.</p><p><strong>Conclusion: </strong>Radiomic features can measure bone health in MRI of proximal femur and has the potential to predict fracture.</p>","PeriodicalId":73101,"journal":{"name":"Frontiers in radiology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10702560/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138814547","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Retraction: CT-based risk factors for mortality of patients with COVID-19 pneumonia in Wuhan, China: a retrospective study 撤稿:基于ct的中国武汉COVID-19肺炎患者死亡危险因素的回顾性研究
Pub Date : 2023-11-09 DOI: 10.3389/fradi.2023.1330251
{"title":"Retraction: CT-based risk factors for mortality of patients with COVID-19 pneumonia in Wuhan, China: a retrospective study","authors":"","doi":"10.3389/fradi.2023.1330251","DOIUrl":"https://doi.org/10.3389/fradi.2023.1330251","url":null,"abstract":"","PeriodicalId":73101,"journal":{"name":"Frontiers in radiology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135292754","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Frontiers in radiology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1